IMREVITE 600 MG SOL INJ SC CT FA VD TRANS X 5 ML
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1018004170030 -
GGREM
505126070025307 -
Código de barras
7908754100096
O que a fonte publica
- Detentor do registro
- BRISTOL-MYERS SQUIBB FARMACÊUTICA LTDA
- Princípios ativos
- NIVOLUMABE
- Embalagem
- 600 MG SOL INJ SC CT FA VD TRANS X 5 ML
- Tipo de produto
- Biológico
- Classe terapêutica
- L1G5 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, PD-1/PD-L1
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "IMREVITE 600 MG SOL INJ SC CT FA VD TRANS X 5 ML",
"holder": "BRISTOL-MYERS SQUIBB FARMACÊUTICA LTDA",
"stripe": null,
"barcodes": [
"7908754100096"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "505126070025307",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": true,
"holderTaxId": "56.998.982/0001-07",
"priceRegime": "Regulado",
"productName": "IMREVITE",
"productType": "Biológico",
"hospitalOnly": true,
"presentation": "600 MG SOL INJ SC CT FA VD TRANS X 5 ML",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "22540.94",
"icms-12": "25614.71",
"icms-17": "27157.75",
"icms-18": "27488.95",
"icms-19": "27828.32",
"icms-20": "28176.18",
"icms-21": "28532.84",
"icms-22": "28898.63",
"icms-23": "29273.94",
"icms-17.5": "27322.35",
"icms-19.5": "28001.17",
"icms-20.5": "28353.39",
"icms-22.5": "29085.09",
"icms-12-alc": "22870.29",
"icms-17-alc": "24247.99",
"icms-18-alc": "24543.70",
"icms-19-alc": "24846.70",
"icms-20-alc": "25157.29",
"icms-21-alc": "25475.75",
"icms-22-alc": "25802.34",
"icms-23-alc": "26137.44",
"withoutTaxes": "20125.84",
"icms-17.5-alc": "24394.95",
"icms-19.5-alc": "25001.04",
"icms-20.5-alc": "25315.50",
"icms-22.5-alc": "25968.81"
},
"pisCofinsList": "Negativa",
"substanceText": "NIVOLUMABE",
"targetSpecies": [],
"consumerPrices": null,
"invalidBarcodes": [],
"activeSubstances": [
"NIVOLUMABE"
],
"therapeuticClass": "L1G5 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, PD-1/PD-L1",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1018004170030",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "L1G5",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:505126070025307"